The Latest in Breast Cancer

FDA advisory committee supports neratinib approval

May 31, 2017

Breast Cancer

Breast cancer liquid biopsies don’t change outcomes....yet

May 25, 2017

Breast Cancer

Five year survival doubles for younger women with de novo MBC

May 25, 2017

Breast Cancer

Continuing tamoxifen costs less, performs better in ER+ breast cancer

May 25, 2017

Breast Cancer

Intraoperative radiation looks good for DCIS

May 21, 2017

Breast Cancer

Positive node risk defined for elderly breast cancer patients

May 20, 2017

Breast Cancer

Forgo axillary dissection for single suspicious node on ultrasound

May 20, 2017

Breast Cancer

Omitting ALND in some breast cancer patients may be the right choice

May 19, 2017

Breast Cancer

More early-stage cancer diagnosis since ACA implementation

May 17, 2017

Three drug combinations represent next level for high-risk breast cancer

May 16, 2017

Breast Cancer

Genes may play role in breast cancer racial disparities

May 12, 2017

Breast Cancer

Decision to remove breast cancer metastases depends on location of lesions

May 9, 2017

Breast Cancer

Androgen receptor screening not ready for triple-negative breast cancer

May 6, 2017

Breast Cancer

Two new biomarkers show breast cancer validity

May 6, 2017

Breast Cancer

Biomarkers come up empty for ribociclib targeting

May 5, 2017

Breast Cancer